Clinical Trial Update: Cardiovascular Study of Lisdexamfetamine in Healthy and Hypertensive Attention Deficit Hyperactivity Disorder Adults [Phase 4]

View source ↗

Summary

Phase 4 cardiovascular safety study results for lisdexamfetamine in adults with ADHD, including healthy and hypertensive participants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Vyvanse (lisdexamfetamine dimesylate)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Attention Deficit Hyperactivity Disorder (ADHD) | Phase 4 | Status: COMPLETED | Results posted: 2012-09-24